TY - JOUR
T1 - Joining European Scientific Forces to Face Pandemics
AU - Vasconcelos, M. Helena
AU - Alcaro, Stefano
AU - Arechavala-Gomeza, Virginia
AU - Baumbach, Jan
AU - Borges, Fernanda
AU - Brevini, Tiziana A.L.
AU - Rivas, Javier De Las
AU - Devaux, Yvan
AU - Hozak, Pavel
AU - Keinänen-Toivola, Minna M.
AU - Lattanzi, Giovanna
AU - Mohr, Thomas
AU - Murovska, Modra
AU - Prusty, Bhupesh K.
AU - Quinlan, Roy A.
AU - Pérez-Sala, Dolores
AU - Scheibenbogen, Carmen
AU - Schmidt, Harald H.H.W.
AU - Silveira, Isabel
AU - Tieri, Paolo
AU - Tolios, Alexander
AU - Riganti, Chiara
N1 - Funding Information:
M.H.V. has grants from FEDER (Fundo Europeu de Desenvolvimento Regional) through COMPETE 2020 and from FCT (Foundation for Science and Technology; POCI-01-0145-FEDER-030457; POCI-01-0145-FEDER-016390: CANCEL STEM). V.A-G. holds a Miguel Servet Fellowship from the ISCIII (CPII17/00004), part-funded by ERDF/FEDER, and acknowledges funding from Ikerbasque (Basque Foundation for Science). T.B. has grants from Carraresi Foundation, EU Horizon 2020 research and innovation programme No 828835 FetOpen and MIND Food's HUB-Regione Lombardia. J.D.L.R. acknowledges funding from ISCIII (project PI18/00591) cofounded by the EU FEDER funds. D.P-S. has grants RTI2018-097624-B-I00 (AEI, MCI, Spain, and ERDF), RD16/0006/0021 (ISCIII, Spain, and ERDF), and CSIC PTI Global Health (PIE 202020E223/CSIC-COV19-100). H.H.H.W.S. has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 777111 (REPO-TRIAL). I.S. acknowledges funding from FCT (Funda??o para a Ci?ncia e Tecnologia), Portugal. C.R. is supported by AIRC (Italian Association for Cancer Research; IG21408). C.R. has funding from PharmaMar. Y.D. acknowledges funding from the National Research Fund (grants C14/BM/8225223, C17/BM/11613033, and COVID-19/2020-1/14719577/miRCOVID), the Ministry of Higher Education and Research, and the Heart Foundation ? Daniel Wagner of Luxembourg. P.T. acknowledges the support of H2020 project iPC ?individualized Paediatric Cure? (826121). These funding agencies and companies had no role in the decision to publish this manuscript, nor were they involved in the writing of this manuscript. This manuscript reflects only the author's view and the European Commission is not responsible for any use that may be made of the information it contains.
Funding Information:
Even though the coordination of such a large network will be difficult, as the main organizers of this currently informal platform, we will work towards obtaining formal recognition by COST, including the necessary funding for the improved coordination of scientific effort when facing pandemic situations. In fact, although COST networks are always very large, COST has had many success stories that prove its effective approach in managing and coordinating networks. One example is the AMiCI ePlatform ( https://sub.samk.fi/projects/amici-eplatform/ ), which is a part of the COST network that was born from a previous COST Action and is supported by Horizon 2020 (the biggest EU-funded research and innovation program for the period 2014–2020). The AMiCI ePlatform aims to define a ‘test bed’ tool for antimicrobial coating solutions in health care.
Funding Information:
M.H.V. has grants from FEDER (Fundo Europeu de Desenvolvimento Regional) through COMPETE 2020 and from FCT (Foundation for Science and Technology; POCI-01-0145-FEDER-030457 ; POCI-01-0145-FEDER-016390 : CANCEL STEM). V.A-G. holds a Miguel Servet Fellowship from the ISCIII (CPII17/00004), part-funded by ERDF/FEDER , and acknowledges funding from Ikerbasque (Basque Foundation for Science). T.B. has grants from Carraresi Foundation , EU Horizon 2020 research and innovation programme No 828835 FetOpen and MIND Food’s HUB-Regione Lombardia. J.D.L.R. acknowledges funding from ISCIII (project PI18/00591 ) cofounded by the EU FEDER funds. D.P-S. has grants RTI2018-097624-B-I00 ( AEI, MCI, Spain, and ERDF ), RD16/0006/0021 ( ISCIII, Spain, and ERDF ), and CSIC PTI Global Health ( PIE 202020E223/CSIC-COV19-100 ). H.H.H.W.S. has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 777111 (REPO-TRIAL). I.S. acknowledges funding from FCT (Fundação para a Ciência e Tecnologia), Portugal. C.R. is supported by AIRC (Italian Association for Cancer Research; IG21408 ). C.R. has funding from PharmaMar . Y.D. acknowledges funding from the National Research Fund (grants C14/BM/8225223 , C17/BM/11613033 , and COVID-19/2020-1/14719577/miRCOVID ), the Ministry of Higher Education and Research, and the Heart Foundation – Daniel Wagner of Luxembourg. P.T. acknowledges the support of H2020 project iPC “individualized Paediatric Cure” ( 826121 ). These funding agencies and companies had no role in the decision to publish this manuscript, nor were they involved in the writing of this manuscript. This manuscript reflects only the author's view and the European Commission is not responsible for any use that may be made of the information it contains.
Publisher Copyright:
© 2020 The Authors
Copyright:
Copyright 2021 Elsevier B.V., All rights reserved.
PY - 2021/2/1
Y1 - 2021/2/1
N2 - Despite the international guidelines on the containment of the coronavirus disease 2019 (COVID-19) pandemic, the European scientific community was not sufficiently prepared to coordinate scientific efforts. To improve preparedness for future pandemics, we have initiated a network of nine European-funded Cooperation in Science and Technology (COST) Actions that can help facilitate inter-, multi-, and trans-disciplinary communication and collaboration.
AB - Despite the international guidelines on the containment of the coronavirus disease 2019 (COVID-19) pandemic, the European scientific community was not sufficiently prepared to coordinate scientific efforts. To improve preparedness for future pandemics, we have initiated a network of nine European-funded Cooperation in Science and Technology (COST) Actions that can help facilitate inter-, multi-, and trans-disciplinary communication and collaboration.
KW - COST Actions
KW - COVID-19
KW - interdisciplinary network
KW - pandemic
UR - https://doi.org/10.1016/j.tim.2020.10.008
UR - https://www.mendeley.com/catalogue/853af234-30ca-31da-b10b-510fd93f4833/
UR - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7716745/pdf/main.pdf
U2 - 10.1016/j.tim.2020.10.008
DO - 10.1016/j.tim.2020.10.008
M3 - Article
C2 - 33288385
AN - SCOPUS:85097878477
SN - 0966-842X
VL - 29
SP - 92
EP - 97
JO - Trends in Microbiology
JF - Trends in Microbiology
IS - 2
ER -
SDG 3 Good Health and Well-being